Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Pembrolizumab for Non–Muscle-Invasive Bladder Cancer — A Costly Therapy in Search of EvidenceJAMA Oncol 2020 Dec 30;[EPub Ahead of Print], J Gill, V Prasad
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.